Global Patent Drug Market Insights, Forecast to 2029

Global Patent Drug Market Insights, Forecast to 2029

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Patent Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Oral
1.2.3 Injection
1.2.4 Other
1.3 Market by Application
1.3.1 Global Patent Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Patent Drug Market Perspective (2018-2029)
2.2 Global Patent Drug Growth Trends by Region
2.2.1 Patent Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Patent Drug Historic Market Size by Region (2018-2023)
2.2.3 Patent Drug Forecasted Market Size by Region (2024-2029)
2.3 Patent Drug Market Dynamics
2.3.1 Patent Drug Industry Trends
2.3.2 Patent Drug Market Drivers
2.3.3 Patent Drug Market Challenges
2.3.4 Patent Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Patent Drug by Players
3.1.1 Global Patent Drug Revenue by Players (2018-2023)
3.1.2 Global Patent Drug Revenue Market Share by Players (2018-2023)
3.2 Global Patent Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Patent Drug, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Patent Drug Market Concentration Ratio
3.4.1 Global Patent Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Patent Drug Revenue in 2022
3.5 Global Key Players of Patent Drug Head office and Area Served
3.6 Global Key Players of Patent Drug, Product and Application
3.7 Global Key Players of Patent Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Patent Drug Breakdown Data by Type
4.1 Global Patent Drug Historic Market Size by Type (2018-2023)
4.2 Global Patent Drug Forecasted Market Size by Type (2024-2029)
5 Patent Drug Breakdown Data by Application
5.1 Global Patent Drug Historic Market Size by Application (2018-2023)
5.2 Global Patent Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Patent Drug Market Size (2018-2029)
6.2 North America Patent Drug Market Size by Type
6.2.1 North America Patent Drug Market Size by Type (2018-2023)
6.2.2 North America Patent Drug Market Size by Type (2024-2029)
6.2.3 North America Patent Drug Market Share by Type (2018-2029)
6.3 North America Patent Drug Market Size by Application
6.3.1 North America Patent Drug Market Size by Application (2018-2023)
6.3.2 North America Patent Drug Market Size by Application (2024-2029)
6.3.3 North America Patent Drug Market Share by Application (2018-2029)
6.4 North America Patent Drug Market Size by Country
6.4.1 North America Patent Drug Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Patent Drug Market Size by Country (2018-2023)
6.4.3 North America Patent Drug Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Patent Drug Market Size (2018-2029)
7.2 Europe Patent Drug Market Size by Type
7.2.1 Europe Patent Drug Market Size by Type (2018-2023)
7.2.2 Europe Patent Drug Market Size by Type (2024-2029)
7.2.3 Europe Patent Drug Market Share by Type (2018-2029)
7.3 Europe Patent Drug Market Size by Application
7.3.1 Europe Patent Drug Market Size by Application (2018-2023)
7.3.2 Europe Patent Drug Market Size by Application (2024-2029)
7.3.3 Europe Patent Drug Market Share by Application (2018-2029)
7.4 Europe Patent Drug Market Size by Country
7.4.1 Europe Patent Drug Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Patent Drug Market Size by Country (2018-2023)
7.4.3 Europe Patent Drug Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Patent Drug Market Size (2018-2029)
8.2 China Patent Drug Market Size by Type
8.2.1 China Patent Drug Market Size by Type (2018-2023)
8.2.2 China Patent Drug Market Size by Type (2024-2029)
8.2.3 China Patent Drug Market Share by Type (2018-2029)
8.3 China Patent Drug Market Size by Application
8.3.1 China Patent Drug Market Size by Application (2018-2023)
8.3.2 China Patent Drug Market Size by Application (2024-2029)
8.3.3 China Patent Drug Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Patent Drug Market Size (2018-2029)
9.2 Asia Patent Drug Market Size by Type
9.2.1 Asia Patent Drug Market Size by Type (2018-2023)
9.2.2 Asia Patent Drug Market Size by Type (2024-2029)
9.2.3 Asia Patent Drug Market Share by Type (2018-2029)
9.3 Asia Patent Drug Market Size by Application
9.3.1 Asia Patent Drug Market Size by Application (2018-2023)
9.3.2 Asia Patent Drug Market Size by Application (2024-2029)
9.3.3 Asia Patent Drug Market Share by Application (2018-2029)
9.4 Asia Patent Drug Market Size by Region
9.4.1 Asia Patent Drug Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Patent Drug Market Size by Region (2018-2023)
9.4.3 Asia Patent Drug Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Patent Drug Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Patent Drug Market Size by Type
10.2.1 Middle East, Africa, and Latin America Patent Drug Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Patent Drug Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Patent Drug Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Patent Drug Market Size by Application
10.3.1 Middle East, Africa, and Latin America Patent Drug Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Patent Drug Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Patent Drug Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Patent Drug Market Size by Country
10.4.1 Middle East, Africa, and Latin America Patent Drug Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Patent Drug Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Patent Drug Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Patent Drug Introduction
11.1.4 Johnson & Johnson Revenue in Patent Drug Business (2018-2023)
11.1.5 Johnson & Johnson Recent Developments
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Patent Drug Introduction
11.2.4 Novartis Revenue in Patent Drug Business (2018-2023)
11.2.5 Novartis Recent Developments
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Patent Drug Introduction
11.3.4 Roche Revenue in Patent Drug Business (2018-2023)
11.3.5 Roche Recent Developments
11.4 AbbVie
11.4.1 AbbVie Company Details
11.4.2 AbbVie Business Overview
11.4.3 AbbVie Patent Drug Introduction
11.4.4 AbbVie Revenue in Patent Drug Business (2018-2023)
11.4.5 AbbVie Recent Developments
11.5 Merck & Co.
11.5.1 Merck & Co. Company Details
11.5.2 Merck & Co. Business Overview
11.5.3 Merck & Co. Patent Drug Introduction
11.5.4 Merck & Co. Revenue in Patent Drug Business (2018-2023)
11.5.5 Merck & Co. Recent Developments
11.6 Bristol Myers Squibb
11.6.1 Bristol Myers Squibb Company Details
11.6.2 Bristol Myers Squibb Business Overview
11.6.3 Bristol Myers Squibb Patent Drug Introduction
11.6.4 Bristol Myers Squibb Revenue in Patent Drug Business (2018-2023)
11.6.5 Bristol Myers Squibb Recent Developments
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Details
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Patent Drug Introduction
11.7.4 GlaxoSmithKline Revenue in Patent Drug Business (2018-2023)
11.7.5 GlaxoSmithKline Recent Developments
11.8 Pfizer
11.8.1 Pfizer Company Details
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Patent Drug Introduction
11.8.4 Pfizer Revenue in Patent Drug Business (2018-2023)
11.8.5 Pfizer Recent Developments
11.9 Sanofi
11.9.1 Sanofi Company Details
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Patent Drug Introduction
11.9.4 Sanofi Revenue in Patent Drug Business (2018-2023)
11.9.5 Sanofi Recent Developments
11.10 Takeda
11.10.1 Takeda Company Details
11.10.2 Takeda Business Overview
11.10.3 Takeda Patent Drug Introduction
11.10.4 Takeda Revenue in Patent Drug Business (2018-2023)
11.10.5 Takeda Recent Developments
11.11 AstraZeneca
11.11.1 AstraZeneca Company Details
11.11.2 AstraZeneca Business Overview
11.11.3 AstraZeneca Patent Drug Introduction
11.11.4 AstraZeneca Revenue in Patent Drug Business (2018-2023)
11.11.5 AstraZeneca Recent Developments
11.12 Bayer
11.12.1 Bayer Company Details
11.12.2 Bayer Business Overview
11.12.3 Bayer Patent Drug Introduction
11.12.4 Bayer Revenue in Patent Drug Business (2018-2023)
11.12.5 Bayer Recent Developments
11.13 Eli Lilly & Co.
11.13.1 Eli Lilly & Co. Company Details
11.13.2 Eli Lilly & Co. Business Overview
11.13.3 Eli Lilly & Co. Patent Drug Introduction
11.13.4 Eli Lilly & Co. Revenue in Patent Drug Business (2018-2023)
11.13.5 Eli Lilly & Co. Recent Developments
11.14 Gilead Sciences
11.14.1 Gilead Sciences Company Details
11.14.2 Gilead Sciences Business Overview
11.14.3 Gilead Sciences Patent Drug Introduction
11.14.4 Gilead Sciences Revenue in Patent Drug Business (2018-2023)
11.14.5 Gilead Sciences Recent Developments
11.15 Amgen
11.15.1 Amgen Company Details
11.15.2 Amgen Business Overview
11.15.3 Amgen Patent Drug Introduction
11.15.4 Amgen Revenue in Patent Drug Business (2018-2023)
11.15.5 Amgen Recent Developments
11.16 Novo Nordisk
11.16.1 Novo Nordisk Company Details
11.16.2 Novo Nordisk Business Overview
11.16.3 Novo Nordisk Patent Drug Introduction
11.16.4 Novo Nordisk Revenue in Patent Drug Business (2018-2023)
11.16.5 Novo Nordisk Recent Developments
11.17 Teva
11.17.1 Teva Company Details
11.17.2 Teva Business Overview
11.17.3 Teva Patent Drug Introduction
11.17.4 Teva Revenue in Patent Drug Business (2018-2023)
11.17.5 Teva Recent Developments
11.18 Boehringer Ingelheim
11.18.1 Boehringer Ingelheim Company Details
11.18.2 Boehringer Ingelheim Business Overview
11.18.3 Boehringer Ingelheim Patent Drug Introduction
11.18.4 Boehringer Ingelheim Revenue in Patent Drug Business (2018-2023)
11.18.5 Boehringer Ingelheim Recent Developments
11.19 Biogen
11.19.1 Biogen Company Details
11.19.2 Biogen Business Overview
11.19.3 Biogen Patent Drug Introduction
11.19.4 Biogen Revenue in Patent Drug Business (2018-2023)
11.19.5 Biogen Recent Developments
11.20 Astellas
11.20.1 Astellas Company Details
11.20.2 Astellas Business Overview
11.20.3 Astellas Patent Drug Introduction
11.20.4 Astellas Revenue in Patent Drug Business (2018-2023)
11.20.5 Astellas Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Patent Drug Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Oral
Table 3. Key Players of Injection
Table 4. Key Players of Other
Table 5. Global Patent Drug Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 6. Global Patent Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Patent Drug Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Patent Drug Market Share by Region (2018-2023)
Table 9. Global Patent Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Patent Drug Market Share by Region (2024-2029)
Table 11. Patent Drug Market Trends
Table 12. Patent Drug Market Drivers
Table 13. Patent Drug Market Challenges
Table 14. Patent Drug Market Restraints
Table 15. Global Patent Drug Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Patent Drug Revenue Share by Players (2018-2023)
Table 17. Global Top Patent Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Patent Drug as of 2022)
Table 18. Global Patent Drug Industry Ranking 2021 VS 2022 VS 2023
Table 19. Global 5 Largest Players Market Share by Patent Drug Revenue (CR5 and HHI) & (2018-2023)
Table 20. Global Key Players of Patent Drug, Headquarters and Area Served
Table 21. Global Key Players of Patent Drug, Product and Application
Table 22. Global Key Players of Patent Drug, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Patent Drug Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Patent Drug Revenue Market Share by Type (2018-2023)
Table 26. Global Patent Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Patent Drug Revenue Market Share by Type (2024-2029)
Table 28. Global Patent Drug Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Patent Drug Revenue Share by Application (2018-2023)
Table 30. Global Patent Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Patent Drug Revenue Share by Application (2024-2029)
Table 32. North America Patent Drug Market Size by Type (2018-2023) & (US$ Million)
Table 33. North America Patent Drug Market Size by Type (2024-2029) & (US$ Million)
Table 34. North America Patent Drug Market Size by Application (2018-2023) & (US$ Million)
Table 35. North America Patent Drug Market Size by Application (2024-2029) & (US$ Million)
Table 36. North America Patent Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. North America Patent Drug Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Patent Drug Market Size by Country (2024-2029) & (US$ Million)
Table 39. Europe Patent Drug Market Size by Type (2018-2023) & (US$ Million)
Table 40. Europe Patent Drug Market Size by Type (2024-2029) & (US$ Million)
Table 41. Europe Patent Drug Market Size by Application (2018-2023) & (US$ Million)
Table 42. Europe Patent Drug Market Size by Application (2024-2029) & (US$ Million)
Table 43. Europe Patent Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Europe Patent Drug Market Size by Country (2018-2023) & (US$ Million)
Table 45. Europe Patent Drug Market Size by Country (2024-2029) & (US$ Million)
Table 46. China Patent Drug Market Size by Type (2018-2023) & (US$ Million)
Table 47. China Patent Drug Market Size by Type (2024-2029) & (US$ Million)
Table 48. China Patent Drug Market Size by Application (2018-2023) & (US$ Million)
Table 49. China Patent Drug Market Size by Application (2024-2029) & (US$ Million)
Table 50. Asia Patent Drug Market Size by Type (2018-2023) & (US$ Million)
Table 51. Asia Patent Drug Market Size by Type (2024-2029) & (US$ Million)
Table 52. Asia Patent Drug Market Size by Application (2018-2023) & (US$ Million)
Table 53. Asia Patent Drug Market Size by Application (2024-2029) & (US$ Million)
Table 54. Asia Patent Drug Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 55. Asia Patent Drug Market Size by Region (2018-2023) & (US$ Million)
Table 56. Asia Patent Drug Market Size by Region (2024-2029) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Patent Drug Market Size by Type (2018-2023) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Patent Drug Market Size by Type (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Patent Drug Market Size by Application (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Patent Drug Market Size by Application (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Patent Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 62. Middle East, Africa, and Latin America Patent Drug Market Size by Country (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Patent Drug Market Size by Country (2024-2029) & (US$ Million)
Table 64. Johnson & Johnson Company Details
Table 65. Johnson & Johnson Business Overview
Table 66. Johnson & Johnson Patent Drug Product
Table 67. Johnson & Johnson Revenue in Patent Drug Business (2018-2023) & (US$ Million)
Table 68. Johnson & Johnson Recent Developments
Table 69. Novartis Company Details
Table 70. Novartis Business Overview
Table 71. Novartis Patent Drug Product
Table 72. Novartis Revenue in Patent Drug Business (2018-2023) & (US$ Million)
Table 73. Novartis Recent Developments
Table 74. Roche Company Details
Table 75. Roche Business Overview
Table 76. Roche Patent Drug Product
Table 77. Roche Revenue in Patent Drug Business (2018-2023) & (US$ Million)
Table 78. Roche Recent Developments
Table 79. AbbVie Company Details
Table 80. AbbVie Business Overview
Table 81. AbbVie Patent Drug Product
Table 82. AbbVie Revenue in Patent Drug Business (2018-2023) & (US$ Million)
Table 83. AbbVie Recent Developments
Table 84. Merck & Co. Company Details
Table 85. Merck & Co. Business Overview
Table 86. Merck & Co. Patent Drug Product
Table 87. Merck & Co. Revenue in Patent Drug Business (2018-2023) & (US$ Million)
Table 88. Merck & Co. Recent Developments
Table 89. Bristol Myers Squibb Company Details
Table 90. Bristol Myers Squibb Business Overview
Table 91. Bristol Myers Squibb Patent Drug Product
Table 92. Bristol Myers Squibb Revenue in Patent Drug Business (2018-2023) & (US$ Million)
Table 93. Bristol Myers Squibb Recent Developments
Table 94. GlaxoSmithKline Company Details
Table 95. GlaxoSmithKline Business Overview
Table 96. GlaxoSmithKline Patent Drug Product
Table 97. GlaxoSmithKline Revenue in Patent Drug Business (2018-2023) & (US$ Million)
Table 98. GlaxoSmithKline Recent Developments
Table 99. Pfizer Company Details
Table 100. Pfizer Business Overview
Table 101. Pfizer Patent Drug Product
Table 102. Pfizer Revenue in Patent Drug Business (2018-2023) & (US$ Million)
Table 103. Pfizer Recent Developments
Table 104. Sanofi Company Details
Table 105. Sanofi Business Overview
Table 106. Sanofi Patent Drug Product
Table 107. Sanofi Revenue in Patent Drug Business (2018-2023) & (US$ Million)
Table 108. Sanofi Recent Developments
Table 109. Takeda Company Details
Table 110. Takeda Business Overview
Table 111. Takeda Patent Drug Product
Table 112. Takeda Revenue in Patent Drug Business (2018-2023) & (US$ Million)
Table 113. Takeda Recent Developments
Table 114. AstraZeneca Company Details
Table 115. AstraZeneca Business Overview
Table 116. AstraZeneca Patent Drug Product
Table 117. AstraZeneca Revenue in Patent Drug Business (2018-2023) & (US$ Million)
Table 118. AstraZeneca Recent Developments
Table 119. Bayer Company Details
Table 120. Bayer Business Overview
Table 121. Bayer Patent Drug Product
Table 122. Bayer Revenue in Patent Drug Business (2018-2023) & (US$ Million)
Table 123. Bayer Recent Developments
Table 124. Eli Lilly & Co. Company Details
Table 125. Eli Lilly & Co. Business Overview
Table 126. Eli Lilly & Co. Patent Drug Product
Table 127. Eli Lilly & Co. Revenue in Patent Drug Business (2018-2023) & (US$ Million)
Table 128. Eli Lilly & Co. Recent Developments
Table 129. Gilead Sciences Company Details
Table 130. Gilead Sciences Business Overview
Table 131. Gilead Sciences Patent Drug Product
Table 132. Gilead Sciences Revenue in Patent Drug Business (2018-2023) & (US$ Million)
Table 133. Gilead Sciences Recent Developments
Table 134. Amgen Company Details
Table 135. Amgen Business Overview
Table 136. Amgen Patent Drug Product
Table 137. Amgen Revenue in Patent Drug Business (2018-2023) & (US$ Million)
Table 138. Amgen Recent Developments
Table 139. Novo Nordisk Company Details
Table 140. Novo Nordisk Business Overview
Table 141. Novo Nordisk Patent Drug Product
Table 142. Novo Nordisk Revenue in Patent Drug Business (2018-2023) & (US$ Million)
Table 143. Novo Nordisk Recent Developments
Table 144. Teva Company Details
Table 145. Teva Business Overview
Table 146. Teva Patent Drug Product
Table 147. Teva Revenue in Patent Drug Business (2018-2023) & (US$ Million)
Table 148. Teva Recent Developments
Table 149. Boehringer Ingelheim Company Details
Table 150. Boehringer Ingelheim Business Overview
Table 151. Boehringer Ingelheim Patent Drug Product
Table 152. Boehringer Ingelheim Revenue in Patent Drug Business (2018-2023) & (US$ Million)
Table 153. Boehringer Ingelheim Recent Developments
Table 154. Biogen Company Details
Table 155. Biogen Business Overview
Table 156. Biogen Patent Drug Product
Table 157. Biogen Revenue in Patent Drug Business (2018-2023) & (US$ Million)
Table 158. Biogen Recent Developments
Table 159. Astellas Company Details
Table 160. Astellas Business Overview
Table 161. Astellas Patent Drug Product
Table 162. Astellas Revenue in Patent Drug Business (2018-2023) & (US$ Million)
Table 163. Astellas Recent Developments
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Patent Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Patent Drug Market Share by Type: 2022 VS 2029
Figure 3. Oral Features
Figure 4. Injection Features
Figure 5. Other Features
Figure 6. Global Patent Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Patent Drug Market Share by Application: 2022 VS 2029
Figure 8. Hospital Case Studies
Figure 9. Retail Pharmacy Case Studies
Figure 10. Patent Drug Report Years Considered
Figure 11. Global Patent Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Patent Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Patent Drug Market Share by Region: 2022 VS 2029
Figure 14. Global Patent Drug Market Share by Players in 2022
Figure 15. Global Top Patent Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Patent Drug as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Patent Drug Revenue in 2022
Figure 17. North America Patent Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Patent Drug Market Share by Type (2018-2029)
Figure 19. North America Patent Drug Market Share by Application (2018-2029)
Figure 20. North America Patent Drug Market Share by Country (2018-2029)
Figure 21. United States Patent Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Patent Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Patent Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 24. Europe Patent Drug Market Share by Type (2018-2029)
Figure 25. Europe Patent Drug Market Share by Application (2018-2029)
Figure 26. Europe Patent Drug Market Share by Country (2018-2029)
Figure 27. Germany Patent Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Patent Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Patent Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Patent Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Patent Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Patent Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. China Patent Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 34. China Patent Drug Market Share by Type (2018-2029)
Figure 35. China Patent Drug Market Share by Application (2018-2029)
Figure 36. Asia Patent Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 37. Asia Patent Drug Market Share by Type (2018-2029)
Figure 38. Asia Patent Drug Market Share by Application (2018-2029)
Figure 39. Asia Patent Drug Market Share by Region (2018-2029)
Figure 40. Japan Patent Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea Patent Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. China Taiwan Patent Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia Patent Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India Patent Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia Patent Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Patent Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Patent Drug Market Share by Type (2018-2029)
Figure 48. Middle East, Africa, and Latin America Patent Drug Market Share by Application (2018-2029)
Figure 49. Middle East, Africa, and Latin America Patent Drug Market Share by Country (2018-2029)
Figure 50. Brazil Patent Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Mexico Patent Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Turkey Patent Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Patent Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Israel Patent Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. GCC Countries Patent Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Johnson & Johnson Revenue Growth Rate in Patent Drug Business (2018-2023)
Figure 57. Novartis Revenue Growth Rate in Patent Drug Business (2018-2023)
Figure 58. Roche Revenue Growth Rate in Patent Drug Business (2018-2023)
Figure 59. AbbVie Revenue Growth Rate in Patent Drug Business (2018-2023)
Figure 60. Merck & Co. Revenue Growth Rate in Patent Drug Business (2018-2023)
Figure 61. Bristol Myers Squibb Revenue Growth Rate in Patent Drug Business (2018-2023)
Figure 62. GlaxoSmithKline Revenue Growth Rate in Patent Drug Business (2018-2023)
Figure 63. Pfizer Revenue Growth Rate in Patent Drug Business (2018-2023)
Figure 64. Sanofi Revenue Growth Rate in Patent Drug Business (2018-2023)
Figure 65. Takeda Revenue Growth Rate in Patent Drug Business (2018-2023)
Figure 66. AstraZeneca Revenue Growth Rate in Patent Drug Business (2018-2023)
Figure 67. Bayer Revenue Growth Rate in Patent Drug Business (2018-2023)
Figure 68. Eli Lilly & Co. Revenue Growth Rate in Patent Drug Business (2018-2023)
Figure 69. Gilead Sciences Revenue Growth Rate in Patent Drug Business (2018-2023)
Figure 70. Amgen Revenue Growth Rate in Patent Drug Business (2018-2023)
Figure 71. Novo Nordisk Revenue Growth Rate in Patent Drug Business (2018-2023)
Figure 72. Teva Revenue Growth Rate in Patent Drug Business (2018-2023)
Figure 73. Boehringer Ingelheim Revenue Growth Rate in Patent Drug Business (2018-2023)
Figure 74. Biogen Revenue Growth Rate in Patent Drug Business (2018-2023)
Figure 75. Astellas Revenue Growth Rate in Patent Drug Business (2018-2023)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs